Martin Shkreli drug-industry ban contempt case

Mapped to your portfolio

Overview

Description Regulators are seeking to hold Martin Shkreli in contempt for allegedly violating a lifetime drug-industry ban through pharmaceutical stock trading. Overview The FTC and seven states asked a Southern District of New York judge to hold Shkreli in contempt. Regulators allege he held more than 60 pharmaceutical stocks and…

Possible scenarios

45%Regulators Win Enforcement0.0%
25%Negotiated Compliance Deal0.0%
20%Case Drags On0.0%

For information only. Not investment advice.

Stories in this saga

1 story, 1 source

Oct 13, 2026
FTC and 7 States Sue Martin Shkreli Over Lifetime Pharma Ban

Martin Shkreli drug-industry ban contempt case

Mapped to your portfolio

Overview

Possible scenarios

Stories in this saga

FTC and 7 States Sue Martin Shkreli Over Lifetime Pharma Ban

Portfolio

Portfolio

Possible scenarios

Mapped to your portfolio

Mapped to your portfolio

Overview

Possible scenarios

Keeping an eye on this saga?

Stories in this saga

FTC and 7 States Sue Martin Shkreli Over Lifetime Pharma Ban

Portfolio

Portfolio

Possible scenarios

Mapped to your portfolio